Biogen Idec shares jump on earnings estimates
Bizjournals.com - Charlotte,NC,USA
It also expects its multiple sclerosis drug Tysabri, which is manufactured in RTP, to have 100000 patients by the end of 2010. Tysabri has proven effective ...
See all stories on this topic

Tysabri gets UK renewal
Irish Times - Ireland
Britain's cost-effectiveness watchdog has again recommended multiple sclerosis drug Tysabri, made by Ireland 's Elan Corp and Biogen Idec, ...
See all stories on this topic

Coping with MS
The Sunday Times - UK
The real seismic advance in the pharmacological treatment of MS in selected cases has been the introduction of Tysabri natalizumab for those patients with ...
See all stories on this topic

'If, Then'.... Amgen Could Recover Much More (AMGN, BIIB)
24/7 Wall St. - New York,NY,USA
If you compare this to what happened to Biogen-Idec (NASDAQ:BIIB) in early 2005 after it panicked and withdrew Tysabri as an MS treatment, the Amgen death ...
See all stories on this topic